The facility recently conducted 70 surgeries, setting an annual goal of reaching 600 procedures and securing accreditation as a regional center within the United States. The specialized technique employed demonstrates a high success rate of 99.6 percent in removing non-melanoma skin cancer. According to visiting specialist in dermatovenereology and Mohs surgery, Prof.
Dr. Aleksandar L. Krunić, this high rate suggests that patients diagnosed with primary basal cell carcinoma have an almost near-certain chance of full recovery.
He contrasted this with the traditional approach to removing non-melanoma skin cancers. The classical removal method involves excising the tissue, suturing the wound, and only submitting the sample to histopathological examination after the surgery is complete. In this established process, laboratory analysis determines whether the tumor reached the surgical margin.
If the pathology reveals that the cancer was not completely excised, the patient must undergo a repeat surgery and obtain a new operative license. This comparison highlights a key procedural difference. The advanced method aims to provide immediate, comprehensive assessment of the margins, thereby minimizing the necessity for subsequent, potentially invasive procedures.
The focus remains on providing definitive care for skin malignancies while adhering to rigorous standards of clinical efficacy and patient safety.
Topics: #method #skin #cancer
